GenSci’s GenSci142 Wins NMPA Nod for Bacterial Vaginosis Clinical Trials
Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced that its subsidiary GenSci...
Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced that its subsidiary GenSci...
Changchun High‑Tech (SHE: 000661) announced today that its wholly‑owned subsidiary, GenSci (GeneScience Pharmaceutical), has received...
Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) on Aug 27, 2025 disclosed...
China-based Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced that its subsidiary...
China-based Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) announced its subsidiary GenScipt...
China-based Changchun High & New Technology Industries (Group) Inc., (SHE: 000661) has received the green...
Changchun High & New Technology Industries (Group) Inc., (SHE: 000661), a leading China-based company, has...
Changchun High & New Technology Industries (Group) Inc. (SHE: 000661), a leading biopharmaceutical company, has...
Changchun High & New Technology Industries (Group) Inc., a Chinese corporation listed on the Shenzhen...
CHANGCHUN—Changchun High & New Technology Industries (Group) Inc., (SHE: 000661), a leading biopharmaceutical company in...
Changchun High & New Technology Industries (Group) Inc. (SHE: 000661), a leading biopharmaceutical company based...
Changchun High & New Technology Industries (Group) Inc., (SHE: 000661), a leading Chinese pharmaceutical company,...
Changchun High & New Technology Industries (Group) Inc., (SHE: 000661) has announced plans to transfer...
China-based Changchun High & New Technology Industries (Group) Inc. (SHE: 000661) has announced that it...